Plasma Rich in Growth Factors Concentrated (PRGFC)

PRGFC is obtained from the patient's own blood, so it is an autologous therapy. After application, local, temporary effects may appear, such as tenderness, slight redness, mild inflammation, small bruises or discomfort at the application points. In clinical studies of PRP-derived hair treatments, the reported adverse effects have generally been mild and transient. At DHI Panamá, each patient is evaluated beforehand to determine whether the treatment is appropriate and to rule out contraindications.

There is no identical number for every patient. The protocol depends on the type of hair loss, degree of alopecia, hair quality, complementary treatments and individual response. As a reference, many protocols use an initial phase of about 3 sessions spaced roughly 4 weeks apart, followed by an evaluation and, when indicated, maintenance sessions. The physician will determine the number and frequency after an assessment.

Results aren't immediate, since the hair needs to complete different phases of its cycle. The first changes may be seen at around 3 to 4 months, while the evolution of density, thickness and quality is usually assessed more fully between 3 and 6 months. At DHI Panamá we follow up to assess progress and determine whether additional sessions or complementary treatments are needed.

Yes. PRGFC can be used as a complementary treatment after a DHI hair transplant, when the physician determines the right time, to support a suitable biological environment around the implanted follicles and the existing hair. It is used as a complement to the transplant, not as a substitute for the procedure or for postoperative care.

No. PRGFC does not create new follicles where they no longer exist. Its main use is to stimulate and improve the condition of the follicles that are still present. When there is advanced loss, the physician may recommend a DHI hair transplant and use PRGFC as part of a complementary protocol.